Literature DB >> 29391273

Knockdown of long noncoding RNA MEG3 impairs VEGF-stimulated endothelial sprouting angiogenesis via modulating VEGFR2 expression in human umbilical vein endothelial cells.

Wenchen Ruan1, Feng Zhao2, Shunyi Zhao1, Luyong Zhang1, Lei Shi3, Tao Pang4.   

Abstract

Long noncoding RNAs is a novel class of RNA molecules, which is closely related to the occurrence and development of human disease. Recent studies have highlighted the importance of MEG3 in angiogenesis and the maintenance of normal function of vascular endothelial cells. However, whether MEG3 contributes to human endothelial cell angiogenesis as well as potential mechanisms are largely unknown. In this work, we found that the high expression level of MEG3 in primary HUVEC was controlled by DNA methylation, and its expression in HUVEC was regulated by HIF-1α under hypoxia condition. Meanwhile, we discovered that knockdown of MEG3 significantly suppressed VEGFR2 mRNA level, but had no influence on gene expression of VEGFR1, Notch1, DLL4 and Hes1. MEG3 reduction also suppressed VEGF-induced endothelial migration and angiogenesis. Furthermore, MEG3 knockdown reduced the tube formation and the spheroid sprouting of primary HUVEC under normoxic and hypoxic conditions. Altogether, MEG3 regulated by HIF-1α is required to maintain VEGFR2 expression in endothelial cells and plays a vital role for VEGFA-mediated endothelial angiogenesis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; HUVEC; MEG3; VEGFR2; lncRNA

Mesh:

Substances:

Year:  2018        PMID: 29391273     DOI: 10.1016/j.gene.2018.01.072

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

1.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 2.  Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis.

Authors:  Jing Zhao; Li Li; Zhong-Ying Han; Zheng-Xin Wang; Lun-Xiu Qin
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 3.  MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.

Authors:  Arwa Al-Rugeebah; Mohammed Alanazi; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2019-02-21       Impact factor: 3.201

Review 4.  Maternally expressed gene 3 in metabolic programming.

Authors:  Samuel Hamilton; Rafael de Cabo; Michel Bernier
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-01       Impact factor: 4.490

5.  MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation.

Authors:  Jason J Gokey; John Snowball; Anusha Sridharan; Joseph P Speth; Katharine E Black; Lida P Hariri; Anne-Karina T Perl; Yan Xu; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2018-09-06

Review 6.  Long noncoding RNAs: emerging roles in pulmonary hypertension.

Authors:  Qi Jin; Zhihui Zhao; Qing Zhao; Xue Yu; Lu Yan; Yi Zhang; Qin Luo; Zhihong Liu
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

Review 7.  Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.

Authors:  Bo Yu; Shusheng Wang
Journal:  Theranostics       Date:  2018-06-08       Impact factor: 11.556

8.  Long Non-coding RNA MEG3 Attenuates the Angiotensin II-Induced Injury of Human Umbilical Vein Endothelial Cells by Interacting With p53.

Authors:  Jingwen Song; Songqun Huang; Kaizhong Wang; Wei Li; Lizhi Pao; Feng Chen; Xianxian Zhao
Journal:  Front Genet       Date:  2019-02-19       Impact factor: 4.599

9.  MicroRNA-26b-5p Inhibits Mouse Liver Fibrogenesis and Angiogenesis by Targeting PDGF Receptor-Beta.

Authors:  Le Yang; Chengbin Dong; Jingjing Yang; Lin Yang; Na Chang; Changbo Qi; Liying Li
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-26

Review 10.  Long Non-coding RNAs in Endothelial Biology.

Authors:  Tyler Weirick; Giuseppe Militello; Shizuka Uchida
Journal:  Front Physiol       Date:  2018-05-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.